Rothschild Investment LLC Sells 2,255 Shares of Johnson & Johnson (NYSE:JNJ)

Rothschild Investment LLC lowered its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 2.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 102,058 shares of the company's stock after selling 2,255 shares during the quarter. Johnson & Johnson makes up approximately 1.1% of Rothschild Investment LLC's holdings, making the stock its 17th biggest holding. Rothschild Investment LLC's holdings in Johnson & Johnson were worth $16,925,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. WealthTrak Capital Management LLC acquired a new stake in shares of Johnson & Johnson during the 4th quarter worth about $26,000. Mountain Hill Investment Partners Corp. acquired a new stake in shares of Johnson & Johnson during the 4th quarter worth about $29,000. Bay Harbor Wealth Management LLC acquired a new stake in shares of Johnson & Johnson during the 4th quarter worth about $32,000. Conquis Financial LLC acquired a new stake in shares of Johnson & Johnson during the 4th quarter worth about $33,000. Finally, Bernard Wealth Management Corp. acquired a new stake in shares of Johnson & Johnson during the 4th quarter worth about $36,000. Institutional investors and hedge funds own 69.55% of the company's stock.

Analysts Set New Price Targets

JNJ has been the subject of several research reports. Guggenheim restated a "neutral" rating on shares of Johnson & Johnson in a research report on Wednesday, April 2nd. Barclays lowered their price objective on shares of Johnson & Johnson from $166.00 to $165.00 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Raymond James lowered their price objective on shares of Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating for the company in a research report on Monday, April 14th. Royal Bank of Canada restated an "outperform" rating and issued a $181.00 price objective on shares of Johnson & Johnson in a research report on Wednesday, April 16th. Finally, Benchmark upgraded shares of Johnson & Johnson to a "strong-buy" rating in a research report on Thursday, April 24th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $170.88.

Johnson & Johnson Trading Up 0.9%

Johnson & Johnson stock traded up $1.41 during midday trading on Friday, hitting $154.99. 15,529,047 shares of the stock were exchanged, compared to its average volume of 7,948,740. The company has a fifty day simple moving average of $154.31 and a two-hundred day simple moving average of $153.65. Johnson & Johnson has a 52 week low of $140.68 and a 52 week high of $169.99. The stock has a market capitalization of $372.92 billion, a PE ratio of 23.31, a P/E/G ratio of 2.56 and a beta of 0.42. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 0.43.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last released its quarterly earnings data on Tuesday, April 15th. The company reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.59 by $0.18. Johnson & Johnson had a net margin of 18.20% and a return on equity of 34.24%. The business had revenue of $21.89 billion for the quarter, compared to analyst estimates of $21.65 billion. Equities research analysts anticipate that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 27th will be paid a dividend of $1.30 per share. This is a positive change from Johnson & Johnson's previous quarterly dividend of $1.24. The ex-dividend date is Tuesday, May 27th. This represents a $5.20 annualized dividend and a yield of 3.36%. Johnson & Johnson's dividend payout ratio (DPR) is presently 57.84%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.